Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

Liver International : Official Journal of the International Association for the Study of the Liver
Emma DayInternational Network on Hepatitis in Substance Users (INHSU)

Abstract

The burden of hepatitis C infection is considerable among people who inject drugs (PWID), with an estimated prevalence of 39%, representing an estimated 6.1 million people who have recently injected drugs living with hepatitis C infection. As such, PWID are a priority population for enhancing prevention, testing, linkage to care, treatment and follow-up care in order to meet World Health Organization (WHO) hepatitis C elimination goals by 2030. There are many barriers to enhancing hepatitis C prevention and care among PWID including poor global coverage of harm reduction services, restrictive drug policies and criminalization of drug use, poor access to health services, low hepatitis C testing, linkage to care and treatment, restrictions for accessing DAA therapy, and the lack of national strategies and government investment to support WHO elimination goals. On 5 September 2017, the International Network of Hepatitis in Substance Users (INHSU) held a roundtable panel of international experts to discuss remaining challenges and future priorities for action from a health systems perspective. The WHO health systems framework comprises six core components: service delivery, health workforce, health information systems, medical proc...Continue Reading

References

Dec 21, 2006·Education for Health : Change in Training & Practice·J-J Guilbert
Sep 15, 2007·The International Journal on Drug Policy·Diana L Sylvestre, Joan E Zweben
Mar 3, 2009·Drug and Alcohol Dependence·Elise RoyJean-François Boivin
Dec 25, 2010·Addiction·Belinda K MoessnerPeer B Christensen
Jun 3, 2011·The New England Journal of Medicine·Sanjeev AroraClifford Qualls
Jul 20, 2011·The American Journal of Gastroenterology·Donna M EvonMichael W Fried
Aug 19, 2011·The Journal of Infectious Diseases·Bryce D SmithCindy M Weinbaum
Sep 8, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Natasha K MartinMatthew Hickman
Sep 17, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bryce D SmithElizabeth A Dinenno
Feb 22, 2012·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Alain H LitwinWilliam N Southern
May 9, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·A JewettC M Weinbaum
Sep 22, 2012·American Journal of Public Health·Mari-Lynn DrainoniWilliam N Southern
Oct 6, 2012·Journal of Substance Abuse Treatment·Melissa R SteinAlain H Litwin
Oct 17, 2012·Annals of Internal Medicine·Sushmita ShivkumarNitika Pant Pai
Jan 31, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrew R LloydDenise Monkley
Apr 5, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Natasha K MartinMatthew Hickman
Jul 3, 2013·Nature Reviews. Gastroenterology & Hepatology·Behzad HajarizadehGregory J Dore
Aug 2, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kimberly PageMaria Prins
Aug 2, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Natasha K MartinPeter Vickerman
Aug 2, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Philip Bruggmann, Alain H Litwin
Aug 2, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maryam AlaviUNKNOWN Enhancing Treatment for Hepatitis C in Opioid Substitution Settings (ETHOS) Study Group
Aug 2, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sione Crawford, Nicky Bath
Aug 2, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Esther J AspinallMargaret E Hellard
Aug 21, 2013·American Journal of Public Health·Carmen L MassonDavid C Perlman
Aug 27, 2013·The International Journal on Drug Policy·Georgina J MacArthurSharon J Hutchinson
Sep 17, 2013·Journal of Gastroenterology and Hepatology·Vincent Wai-Sun WongHenry Lik-Yuen Chan
Apr 10, 2014·Journal of Viral Hepatitis·P BruggmannS J Hindman
May 27, 2014·Journal of Health Care for the Poor and Underserved·Robert J RooseAlain H Litwin
Aug 29, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Margaret HellardEmma McBryde
Sep 30, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Georgina McAllisterSharon J Hutchinson
Jan 7, 2015·Journal of Viral Hepatitis·V SaraswatE Gower

❮ Previous
Next ❯

Citations

Mar 23, 2019·The International Journal of Health Planning and Management·Davoud PourmarziLisa Hall
Jul 28, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew J AkiyamaAlain H Litwin
Jul 29, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kelly Safreed-HarmonJeffrey V Lazarus
Oct 15, 2019·Journal of Clinical and Translational Hepatology·Sammy SaabGina Choi
Apr 19, 2020·Digestive Diseases and Sciences·Denis OuzanUNKNOWN HELIOS study group
Sep 26, 2020·BMC Infectious Diseases·Marta TorrensEberhard Schatz
Nov 30, 2019·The Journal of Antimicrobial Chemotherapy·Jürgen Kurt Rockstroh, Yazdan Yazdanpanah
Nov 5, 2020·Harm Reduction Journal·Camila A PicchioJeffrey V Lazarus
Aug 3, 2020·The International Journal on Drug Policy·Maia ButsashviliFrancisco Averhoff
Feb 1, 2021·The International Journal on Drug Policy·Pablo RyanSalvador Resino
Feb 11, 2021·Journal of Clinical Medicine·Isidoro MartínezSalvador Resino
Jun 27, 2021·BMC Infectious Diseases·Guillermo Z Martínez-PérezSonjelle Shilton
Sep 21, 2021·Gastroenterología y hepatología·José Carlos Fernández de Cañete CamachoJosé María Moreno Planas
Jun 9, 2020·GE Portuguese Journal of Gastroenterology·José Velosa, Guilherme Macedo
Nov 13, 2021·Liver International : Official Journal of the International Association for the Study of the Liver·Jorge ValenciaPablo Ryan
Dec 7, 2021·Alimentary Pharmacology & Therapeutics·Jeffrey V LazarusTerry T-K Huang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.